These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23831555)

  • 1. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.
    Lister JA; Capper A; Zeng Z; Mathers ME; Richardson J; Paranthaman K; Jackson IJ; Elizabeth Patton E
    J Invest Dermatol; 2014 Jan; 134(1):133-140. PubMed ID: 23831555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of MITF on melanoma development: news from bench and bedside.
    Roider EM; Fisher DE
    J Invest Dermatol; 2014 Jan; 134(1):16-17. PubMed ID: 24352080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXQ1 controls the induced differentiation of melanocytic cells.
    Bagati A; Bianchi-Smiraglia A; Moparthy S; Kolesnikova K; Fink EE; Kolesnikova M; Roll MV; Jowdy P; Wolff DW; Polechetti A; Yun DH; Lipchick BC; Paul LM; Wrazen B; Moparthy K; Mudambi S; Morozevich GE; Georgieva SG; Wang J; Shafirstein G; Liu S; Kandel ES; Berman AE; Box NF; Paragh G; Nikiforov MA
    Cell Death Differ; 2018 Jun; 25(6):1040-1049. PubMed ID: 29463842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma Regression and Recurrence in Zebrafish.
    Wojciechowska S; Zeng Z; Lister JA; Ceol CJ; Patton EE
    Methods Mol Biol; 2016; 1451():143-53. PubMed ID: 27464806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.
    Kido K; Sumimoto H; Asada S; Okada SM; Yaguchi T; Kawamura N; Miyagishi M; Saida T; Kawakami Y
    Cancer Sci; 2009 Oct; 100(10):1863-9. PubMed ID: 19659611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
    Maskin CR; Raman R; Houvras Y
    Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent mutations in the MITF pathway in melanoma.
    Cronin JC; Wunderlich J; Loftus SK; Prickett TD; Wei X; Ridd K; Vemula S; Burrell AS; Agrawal NS; Lin JC; Banister CE; Buckhaults P; Rosenberg SA; Bastian BC; Pavan WJ; Samuels Y
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):435-44. PubMed ID: 19422606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
    Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
    PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
    Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT
    Phung B; Kazi JU; Lundby A; Bergsteinsdottir K; Sun J; Goding CR; Jönsson G; Olsen JV; Steingrímsson E; Rönnstrand L
    Mol Cancer Res; 2017 Sep; 15(9):1265-1274. PubMed ID: 28584020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
    Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M
    J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution.
    Louphrasitthiphol P; Siddaway R; Loffreda A; Pogenberg V; Friedrichsen H; Schepsky A; Zeng Z; Lu M; Strub T; Freter R; Lisle R; Suer E; Thomas B; Schuster-Böckler B; Filippakopoulos P; Middleton M; Lu X; Patton EE; Davidson I; Lambert JP; Wilmanns M; Steingrímsson E; Mazza D; Goding CR
    Mol Cell; 2020 Aug; 79(3):472-487.e10. PubMed ID: 32531202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF.
    Seberg HE; Van Otterloo E; Loftus SK; Liu H; Bonde G; Sompallae R; Gildea DE; Santana JF; Manak JR; Pavan WJ; Williams T; Cornell RA
    PLoS Genet; 2017 Mar; 13(3):e1006636. PubMed ID: 28249010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid melanoma induction in mice expressing oncogenic Braf
    Urtatiz O; Samani AMV; Kopp JL; Van Raamsdonk CD
    Pigment Cell Melanoma Res; 2018 Jul; 31(4):541-544. PubMed ID: 29266793
    [No Abstract]   [Full Text] [Related]  

  • 20. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
    Haq R; Yokoyama S; Hawryluk EB; Jönsson GB; Frederick DT; McHenry K; Porter D; Tran TN; Love KT; Langer R; Anderson DG; Garraway LA; Duncan LM; Morton DL; Hoon DS; Wargo JA; Song JS; Fisher DE
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4321-6. PubMed ID: 23447565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.